[Hepatotoxicity of antituberculosis drugs: practical implications for monitoring].
Durand
F
F
Service d'Hépatologie et INSERM U24, Hôpital Reaujon, Clichy.
Bernuau
J
J
Pessayre
D
D
D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis / Q000517:prevention & control
D000995:Antitubercular Agents
Hépatotoxicité des médicaments antituberuleux: implications partiques pour la surveillance.